Vitamin D deficiency is common in patients with RA and linked to disease activity, but circulating levels are unaffected by TNFα blockade: results from a prospective cohort study

Ann Rheum Dis. 2011 Jun;70(6):1165-7. doi: 10.1136/ard.2010.137265. Epub 2010 Nov 3.
No abstract available

Publication types

  • Clinical Trial
  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adalimumab
  • Adult
  • Aged
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents / therapeutic use*
  • Arthritis, Rheumatoid / complications*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Prospective Studies
  • Seasons
  • Tumor Necrosis Factor-alpha / antagonists & inhibitors*
  • Vitamin D / analogs & derivatives
  • Vitamin D / blood
  • Vitamin D Deficiency / etiology*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antirheumatic Agents
  • Tumor Necrosis Factor-alpha
  • Vitamin D
  • 25-hydroxyvitamin D
  • Adalimumab